Global Influenza Diagnostics Supply, Demand and Key Producers, 2024-2030

Global Influenza Diagnostics Supply, Demand and Key Producers, 2024-2030

Page: 123

Published Date: 08 Feb 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Influenza Diagnostics market size is expected to reach $ 3620.3 million by 2030, rising at a market growth of 6.0% CAGR during the forecast period (2024-2030).

North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.

The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

This report studies the global Influenza Diagnostics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Influenza Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Influenza Diagnostics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Influenza Diagnostics total market, 2019-2030, (USD Million)
Global Influenza Diagnostics total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Influenza Diagnostics total market, key domestic companies and share, (USD Million)
Global Influenza Diagnostics revenue by player and market share 2019-2024, (USD Million)
Global Influenza Diagnostics total market by Type, CAGR, 2019-2030, (USD Million)
Global Influenza Diagnostics total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Influenza Diagnostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience and BioMerieux, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Influenza Diagnostics market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Influenza Diagnostics Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Influenza Diagnostics Market, Segmentation by Type
RIDT
RT-PCR
Cell Culture
Others

Global Influenza Diagnostics Market, Segmentation by Application
Hospitals
POCT
Others

Companies Profiled:
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific

Key Questions Answered
1. How big is the global Influenza Diagnostics market?
2. What is the demand of the global Influenza Diagnostics market?
3. What is the year over year growth of the global Influenza Diagnostics market?
4. What is the total value of the global Influenza Diagnostics market?
5. Who are the major players in the global Influenza Diagnostics market?
btl

Table of Contents

1 Supply Summary
1.1 Influenza Diagnostics Introduction
1.2 World Influenza Diagnostics Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Influenza Diagnostics Total Market by Region (by Headquarter Location)
1.3.1 World Influenza Diagnostics Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Influenza Diagnostics Market Size (2019-2030)
1.3.3 China Influenza Diagnostics Market Size (2019-2030)
1.3.4 Europe Influenza Diagnostics Market Size (2019-2030)
1.3.5 Japan Influenza Diagnostics Market Size (2019-2030)
1.3.6 South Korea Influenza Diagnostics Market Size (2019-2030)
1.3.7 ASEAN Influenza Diagnostics Market Size (2019-2030)
1.3.8 India Influenza Diagnostics Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Influenza Diagnostics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Influenza Diagnostics Major Market Trends

2 Demand Summary
2.1 World Influenza Diagnostics Consumption Value (2019-2030)
2.2 World Influenza Diagnostics Consumption Value by Region
2.2.1 World Influenza Diagnostics Consumption Value by Region (2019-2024)
2.2.2 World Influenza Diagnostics Consumption Value Forecast by Region (2025-2030)
2.3 United States Influenza Diagnostics Consumption Value (2019-2030)
2.4 China Influenza Diagnostics Consumption Value (2019-2030)
2.5 Europe Influenza Diagnostics Consumption Value (2019-2030)
2.6 Japan Influenza Diagnostics Consumption Value (2019-2030)
2.7 South Korea Influenza Diagnostics Consumption Value (2019-2030)
2.8 ASEAN Influenza Diagnostics Consumption Value (2019-2030)
2.9 India Influenza Diagnostics Consumption Value (2019-2030)

3 World Influenza Diagnostics Companies Competitive Analysis
3.1 World Influenza Diagnostics Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Influenza Diagnostics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Influenza Diagnostics in 2023
3.2.3 Global Concentration Ratios (CR8) for Influenza Diagnostics in 2023
3.3 Influenza Diagnostics Company Evaluation Quadrant
3.4 Influenza Diagnostics Market: Overall Company Footprint Analysis
3.4.1 Influenza Diagnostics Market: Region Footprint
3.4.2 Influenza Diagnostics Market: Company Product Type Footprint
3.4.3 Influenza Diagnostics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Influenza Diagnostics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Influenza Diagnostics Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Influenza Diagnostics Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Influenza Diagnostics Consumption Value Comparison
4.2.1 United States VS China: Influenza Diagnostics Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Influenza Diagnostics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Influenza Diagnostics Companies and Market Share, 2019-2024
4.3.1 United States Based Influenza Diagnostics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Influenza Diagnostics Revenue, (2019-2024)
4.4 China Based Companies Influenza Diagnostics Revenue and Market Share, 2019-2024
4.4.1 China Based Influenza Diagnostics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Influenza Diagnostics Revenue, (2019-2024)
4.5 Rest of World Based Influenza Diagnostics Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Influenza Diagnostics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Influenza Diagnostics Revenue, (2019-2024)

5 Market Analysis by Type
5.1 World Influenza Diagnostics Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 RIDT
5.2.2 RT-PCR
5.2.3 Cell Culture
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Influenza Diagnostics Market Size by Type (2019-2024)
5.3.2 World Influenza Diagnostics Market Size by Type (2025-2030)
5.3.3 World Influenza Diagnostics Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
6.1 World Influenza Diagnostics Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 POCT
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Influenza Diagnostics Market Size by Application (2019-2024)
6.3.2 World Influenza Diagnostics Market Size by Application (2025-2030)
6.3.3 World Influenza Diagnostics Market Size by Application (2019-2030)

7 Company Profiles
7.1 BD
7.1.1 BD Details
7.1.2 BD Major Business
7.1.3 BD Influenza Diagnostics Product and Services
7.1.4 BD Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 BD Recent Developments/Updates
7.1.6 BD Competitive Strengths & Weaknesses
7.2 Abbott (Include Alere)
7.2.1 Abbott (Include Alere) Details
7.2.2 Abbott (Include Alere) Major Business
7.2.3 Abbott (Include Alere) Influenza Diagnostics Product and Services
7.2.4 Abbott (Include Alere) Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Abbott (Include Alere) Recent Developments/Updates
7.2.6 Abbott (Include Alere) Competitive Strengths & Weaknesses
7.3 Roche
7.3.1 Roche Details
7.3.2 Roche Major Business
7.3.3 Roche Influenza Diagnostics Product and Services
7.3.4 Roche Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Roche Recent Developments/Updates
7.3.6 Roche Competitive Strengths & Weaknesses
7.4 SIEMENS
7.4.1 SIEMENS Details
7.4.2 SIEMENS Major Business
7.4.3 SIEMENS Influenza Diagnostics Product and Services
7.4.4 SIEMENS Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 SIEMENS Recent Developments/Updates
7.4.6 SIEMENS Competitive Strengths & Weaknesses
7.5 Analytik Jena
7.5.1 Analytik Jena Details
7.5.2 Analytik Jena Major Business
7.5.3 Analytik Jena Influenza Diagnostics Product and Services
7.5.4 Analytik Jena Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Analytik Jena Recent Developments/Updates
7.5.6 Analytik Jena Competitive Strengths & Weaknesses
7.6 Quidel
7.6.1 Quidel Details
7.6.2 Quidel Major Business
7.6.3 Quidel Influenza Diagnostics Product and Services
7.6.4 Quidel Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Quidel Recent Developments/Updates
7.6.6 Quidel Competitive Strengths & Weaknesses
7.7 Thermo Fisher
7.7.1 Thermo Fisher Details
7.7.2 Thermo Fisher Major Business
7.7.3 Thermo Fisher Influenza Diagnostics Product and Services
7.7.4 Thermo Fisher Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Thermo Fisher Recent Developments/Updates
7.7.6 Thermo Fisher Competitive Strengths & Weaknesses
7.8 Meridian Bioscience
7.8.1 Meridian Bioscience Details
7.8.2 Meridian Bioscience Major Business
7.8.3 Meridian Bioscience Influenza Diagnostics Product and Services
7.8.4 Meridian Bioscience Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Meridian Bioscience Recent Developments/Updates
7.8.6 Meridian Bioscience Competitive Strengths & Weaknesses
7.9 BioMerieux
7.9.1 BioMerieux Details
7.9.2 BioMerieux Major Business
7.9.3 BioMerieux Influenza Diagnostics Product and Services
7.9.4 BioMerieux Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 BioMerieux Recent Developments/Updates
7.9.6 BioMerieux Competitive Strengths & Weaknesses
7.10 Sekisui Diagnostics
7.10.1 Sekisui Diagnostics Details
7.10.2 Sekisui Diagnostics Major Business
7.10.3 Sekisui Diagnostics Influenza Diagnostics Product and Services
7.10.4 Sekisui Diagnostics Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Sekisui Diagnostics Recent Developments/Updates
7.10.6 Sekisui Diagnostics Competitive Strengths & Weaknesses
7.11 Response Biomedical
7.11.1 Response Biomedical Details
7.11.2 Response Biomedical Major Business
7.11.3 Response Biomedical Influenza Diagnostics Product and Services
7.11.4 Response Biomedical Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Response Biomedical Recent Developments/Updates
7.11.6 Response Biomedical Competitive Strengths & Weaknesses
7.12 SA Scientific
7.12.1 SA Scientific Details
7.12.2 SA Scientific Major Business
7.12.3 SA Scientific Influenza Diagnostics Product and Services
7.12.4 SA Scientific Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 SA Scientific Recent Developments/Updates
7.12.6 SA Scientific Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Influenza Diagnostics Industry Chain
8.2 Influenza Diagnostics Upstream Analysis
8.3 Influenza Diagnostics Midstream Analysis
8.4 Influenza Diagnostics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Influenza Diagnostics Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Influenza Diagnostics Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Influenza Diagnostics Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Influenza Diagnostics Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Influenza Diagnostics Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Influenza Diagnostics Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Influenza Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Influenza Diagnostics Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Influenza Diagnostics Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Influenza Diagnostics Players in 2023
Table 12. World Influenza Diagnostics Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Influenza Diagnostics Company Evaluation Quadrant
Table 14. Head Office of Key Influenza Diagnostics Player
Table 15. Influenza Diagnostics Market: Company Product Type Footprint
Table 16. Influenza Diagnostics Market: Company Product Application Footprint
Table 17. Influenza Diagnostics Mergers & Acquisitions Activity
Table 18. United States VS China Influenza Diagnostics Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Influenza Diagnostics Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Influenza Diagnostics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Influenza Diagnostics Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Influenza Diagnostics Revenue Market Share (2019-2024)
Table 23. China Based Influenza Diagnostics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Influenza Diagnostics Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Influenza Diagnostics Revenue Market Share (2019-2024)
Table 26. Rest of World Based Influenza Diagnostics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Influenza Diagnostics Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Influenza Diagnostics Revenue Market Share (2019-2024)
Table 29. World Influenza Diagnostics Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Influenza Diagnostics Market Size by Type (2019-2024) & (USD Million)
Table 31. World Influenza Diagnostics Market Size by Type (2025-2030) & (USD Million)
Table 32. World Influenza Diagnostics Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Influenza Diagnostics Market Size by Application (2019-2024) & (USD Million)
Table 34. World Influenza Diagnostics Market Size by Application (2025-2030) & (USD Million)
Table 35. BD Basic Information, Area Served and Competitors
Table 36. BD Major Business
Table 37. BD Influenza Diagnostics Product and Services
Table 38. BD Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. BD Recent Developments/Updates
Table 40. BD Competitive Strengths & Weaknesses
Table 41. Abbott (Include Alere) Basic Information, Area Served and Competitors
Table 42. Abbott (Include Alere) Major Business
Table 43. Abbott (Include Alere) Influenza Diagnostics Product and Services
Table 44. Abbott (Include Alere) Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Abbott (Include Alere) Recent Developments/Updates
Table 46. Abbott (Include Alere) Competitive Strengths & Weaknesses
Table 47. Roche Basic Information, Area Served and Competitors
Table 48. Roche Major Business
Table 49. Roche Influenza Diagnostics Product and Services
Table 50. Roche Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Roche Recent Developments/Updates
Table 52. Roche Competitive Strengths & Weaknesses
Table 53. SIEMENS Basic Information, Area Served and Competitors
Table 54. SIEMENS Major Business
Table 55. SIEMENS Influenza Diagnostics Product and Services
Table 56. SIEMENS Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. SIEMENS Recent Developments/Updates
Table 58. SIEMENS Competitive Strengths & Weaknesses
Table 59. Analytik Jena Basic Information, Area Served and Competitors
Table 60. Analytik Jena Major Business
Table 61. Analytik Jena Influenza Diagnostics Product and Services
Table 62. Analytik Jena Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Analytik Jena Recent Developments/Updates
Table 64. Analytik Jena Competitive Strengths & Weaknesses
Table 65. Quidel Basic Information, Area Served and Competitors
Table 66. Quidel Major Business
Table 67. Quidel Influenza Diagnostics Product and Services
Table 68. Quidel Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Quidel Recent Developments/Updates
Table 70. Quidel Competitive Strengths & Weaknesses
Table 71. Thermo Fisher Basic Information, Area Served and Competitors
Table 72. Thermo Fisher Major Business
Table 73. Thermo Fisher Influenza Diagnostics Product and Services
Table 74. Thermo Fisher Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Thermo Fisher Recent Developments/Updates
Table 76. Thermo Fisher Competitive Strengths & Weaknesses
Table 77. Meridian Bioscience Basic Information, Area Served and Competitors
Table 78. Meridian Bioscience Major Business
Table 79. Meridian Bioscience Influenza Diagnostics Product and Services
Table 80. Meridian Bioscience Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Meridian Bioscience Recent Developments/Updates
Table 82. Meridian Bioscience Competitive Strengths & Weaknesses
Table 83. BioMerieux Basic Information, Area Served and Competitors
Table 84. BioMerieux Major Business
Table 85. BioMerieux Influenza Diagnostics Product and Services
Table 86. BioMerieux Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. BioMerieux Recent Developments/Updates
Table 88. BioMerieux Competitive Strengths & Weaknesses
Table 89. Sekisui Diagnostics Basic Information, Area Served and Competitors
Table 90. Sekisui Diagnostics Major Business
Table 91. Sekisui Diagnostics Influenza Diagnostics Product and Services
Table 92. Sekisui Diagnostics Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Sekisui Diagnostics Recent Developments/Updates
Table 94. Sekisui Diagnostics Competitive Strengths & Weaknesses
Table 95. Response Biomedical Basic Information, Area Served and Competitors
Table 96. Response Biomedical Major Business
Table 97. Response Biomedical Influenza Diagnostics Product and Services
Table 98. Response Biomedical Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Response Biomedical Recent Developments/Updates
Table 100. SA Scientific Basic Information, Area Served and Competitors
Table 101. SA Scientific Major Business
Table 102. SA Scientific Influenza Diagnostics Product and Services
Table 103. SA Scientific Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 104. Global Key Players of Influenza Diagnostics Upstream (Raw Materials)
Table 105. Influenza Diagnostics Typical Customers
List of Figure
Figure 1. Influenza Diagnostics Picture
Figure 2. World Influenza Diagnostics Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Influenza Diagnostics Total Market Size (2019-2030) & (USD Million)
Figure 4. World Influenza Diagnostics Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Influenza Diagnostics Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Influenza Diagnostics Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Influenza Diagnostics Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Influenza Diagnostics Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Influenza Diagnostics Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Influenza Diagnostics Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Influenza Diagnostics Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Influenza Diagnostics Revenue (2019-2030) & (USD Million)
Figure 13. Influenza Diagnostics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Influenza Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 16. World Influenza Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Influenza Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 18. China Influenza Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Influenza Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Influenza Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Influenza Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Influenza Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 23. India Influenza Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Influenza Diagnostics by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Influenza Diagnostics Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Influenza Diagnostics Markets in 2023
Figure 27. United States VS China: Influenza Diagnostics Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Influenza Diagnostics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Influenza Diagnostics Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Influenza Diagnostics Market Size Market Share by Type in 2023
Figure 31. RIDT
Figure 32. RT-PCR
Figure 33. Cell Culture
Figure 34. Others
Figure 35. World Influenza Diagnostics Market Size Market Share by Type (2019-2030)
Figure 36. World Influenza Diagnostics Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 37. World Influenza Diagnostics Market Size Market Share by Application in 2023
Figure 38. Hospitals
Figure 39. POCT
Figure 40. Others
Figure 41. Influenza Diagnostics Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
btl

Related Reports

Global Influenza Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029 xian22

Global Influenza Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Medical Care

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Influenza Diagnostics Supply, Demand and Key Producers, 2024-2030

Global Influenza Diagnostics Supply, Demand and Key Producers, 2024-2030

Page: 123

Published Date: 08 Feb 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Influenza Diagnostics market size is expected to reach $ 3620.3 million by 2030, rising at a market growth of 6.0% CAGR during the forecast period (2024-2030).

North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.

The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

This report studies the global Influenza Diagnostics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Influenza Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Influenza Diagnostics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Influenza Diagnostics total market, 2019-2030, (USD Million)
Global Influenza Diagnostics total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Influenza Diagnostics total market, key domestic companies and share, (USD Million)
Global Influenza Diagnostics revenue by player and market share 2019-2024, (USD Million)
Global Influenza Diagnostics total market by Type, CAGR, 2019-2030, (USD Million)
Global Influenza Diagnostics total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Influenza Diagnostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience and BioMerieux, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Influenza Diagnostics market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Influenza Diagnostics Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Influenza Diagnostics Market, Segmentation by Type
RIDT
RT-PCR
Cell Culture
Others

Global Influenza Diagnostics Market, Segmentation by Application
Hospitals
POCT
Others

Companies Profiled:
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific

Key Questions Answered
1. How big is the global Influenza Diagnostics market?
2. What is the demand of the global Influenza Diagnostics market?
3. What is the year over year growth of the global Influenza Diagnostics market?
4. What is the total value of the global Influenza Diagnostics market?
5. Who are the major players in the global Influenza Diagnostics market?
btl

Table of Contents

1 Supply Summary
1.1 Influenza Diagnostics Introduction
1.2 World Influenza Diagnostics Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Influenza Diagnostics Total Market by Region (by Headquarter Location)
1.3.1 World Influenza Diagnostics Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Influenza Diagnostics Market Size (2019-2030)
1.3.3 China Influenza Diagnostics Market Size (2019-2030)
1.3.4 Europe Influenza Diagnostics Market Size (2019-2030)
1.3.5 Japan Influenza Diagnostics Market Size (2019-2030)
1.3.6 South Korea Influenza Diagnostics Market Size (2019-2030)
1.3.7 ASEAN Influenza Diagnostics Market Size (2019-2030)
1.3.8 India Influenza Diagnostics Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Influenza Diagnostics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Influenza Diagnostics Major Market Trends

2 Demand Summary
2.1 World Influenza Diagnostics Consumption Value (2019-2030)
2.2 World Influenza Diagnostics Consumption Value by Region
2.2.1 World Influenza Diagnostics Consumption Value by Region (2019-2024)
2.2.2 World Influenza Diagnostics Consumption Value Forecast by Region (2025-2030)
2.3 United States Influenza Diagnostics Consumption Value (2019-2030)
2.4 China Influenza Diagnostics Consumption Value (2019-2030)
2.5 Europe Influenza Diagnostics Consumption Value (2019-2030)
2.6 Japan Influenza Diagnostics Consumption Value (2019-2030)
2.7 South Korea Influenza Diagnostics Consumption Value (2019-2030)
2.8 ASEAN Influenza Diagnostics Consumption Value (2019-2030)
2.9 India Influenza Diagnostics Consumption Value (2019-2030)

3 World Influenza Diagnostics Companies Competitive Analysis
3.1 World Influenza Diagnostics Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Influenza Diagnostics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Influenza Diagnostics in 2023
3.2.3 Global Concentration Ratios (CR8) for Influenza Diagnostics in 2023
3.3 Influenza Diagnostics Company Evaluation Quadrant
3.4 Influenza Diagnostics Market: Overall Company Footprint Analysis
3.4.1 Influenza Diagnostics Market: Region Footprint
3.4.2 Influenza Diagnostics Market: Company Product Type Footprint
3.4.3 Influenza Diagnostics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Influenza Diagnostics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Influenza Diagnostics Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Influenza Diagnostics Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Influenza Diagnostics Consumption Value Comparison
4.2.1 United States VS China: Influenza Diagnostics Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Influenza Diagnostics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Influenza Diagnostics Companies and Market Share, 2019-2024
4.3.1 United States Based Influenza Diagnostics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Influenza Diagnostics Revenue, (2019-2024)
4.4 China Based Companies Influenza Diagnostics Revenue and Market Share, 2019-2024
4.4.1 China Based Influenza Diagnostics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Influenza Diagnostics Revenue, (2019-2024)
4.5 Rest of World Based Influenza Diagnostics Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Influenza Diagnostics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Influenza Diagnostics Revenue, (2019-2024)

5 Market Analysis by Type
5.1 World Influenza Diagnostics Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 RIDT
5.2.2 RT-PCR
5.2.3 Cell Culture
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Influenza Diagnostics Market Size by Type (2019-2024)
5.3.2 World Influenza Diagnostics Market Size by Type (2025-2030)
5.3.3 World Influenza Diagnostics Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
6.1 World Influenza Diagnostics Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 POCT
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Influenza Diagnostics Market Size by Application (2019-2024)
6.3.2 World Influenza Diagnostics Market Size by Application (2025-2030)
6.3.3 World Influenza Diagnostics Market Size by Application (2019-2030)

7 Company Profiles
7.1 BD
7.1.1 BD Details
7.1.2 BD Major Business
7.1.3 BD Influenza Diagnostics Product and Services
7.1.4 BD Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 BD Recent Developments/Updates
7.1.6 BD Competitive Strengths & Weaknesses
7.2 Abbott (Include Alere)
7.2.1 Abbott (Include Alere) Details
7.2.2 Abbott (Include Alere) Major Business
7.2.3 Abbott (Include Alere) Influenza Diagnostics Product and Services
7.2.4 Abbott (Include Alere) Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Abbott (Include Alere) Recent Developments/Updates
7.2.6 Abbott (Include Alere) Competitive Strengths & Weaknesses
7.3 Roche
7.3.1 Roche Details
7.3.2 Roche Major Business
7.3.3 Roche Influenza Diagnostics Product and Services
7.3.4 Roche Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Roche Recent Developments/Updates
7.3.6 Roche Competitive Strengths & Weaknesses
7.4 SIEMENS
7.4.1 SIEMENS Details
7.4.2 SIEMENS Major Business
7.4.3 SIEMENS Influenza Diagnostics Product and Services
7.4.4 SIEMENS Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 SIEMENS Recent Developments/Updates
7.4.6 SIEMENS Competitive Strengths & Weaknesses
7.5 Analytik Jena
7.5.1 Analytik Jena Details
7.5.2 Analytik Jena Major Business
7.5.3 Analytik Jena Influenza Diagnostics Product and Services
7.5.4 Analytik Jena Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Analytik Jena Recent Developments/Updates
7.5.6 Analytik Jena Competitive Strengths & Weaknesses
7.6 Quidel
7.6.1 Quidel Details
7.6.2 Quidel Major Business
7.6.3 Quidel Influenza Diagnostics Product and Services
7.6.4 Quidel Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Quidel Recent Developments/Updates
7.6.6 Quidel Competitive Strengths & Weaknesses
7.7 Thermo Fisher
7.7.1 Thermo Fisher Details
7.7.2 Thermo Fisher Major Business
7.7.3 Thermo Fisher Influenza Diagnostics Product and Services
7.7.4 Thermo Fisher Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Thermo Fisher Recent Developments/Updates
7.7.6 Thermo Fisher Competitive Strengths & Weaknesses
7.8 Meridian Bioscience
7.8.1 Meridian Bioscience Details
7.8.2 Meridian Bioscience Major Business
7.8.3 Meridian Bioscience Influenza Diagnostics Product and Services
7.8.4 Meridian Bioscience Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Meridian Bioscience Recent Developments/Updates
7.8.6 Meridian Bioscience Competitive Strengths & Weaknesses
7.9 BioMerieux
7.9.1 BioMerieux Details
7.9.2 BioMerieux Major Business
7.9.3 BioMerieux Influenza Diagnostics Product and Services
7.9.4 BioMerieux Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 BioMerieux Recent Developments/Updates
7.9.6 BioMerieux Competitive Strengths & Weaknesses
7.10 Sekisui Diagnostics
7.10.1 Sekisui Diagnostics Details
7.10.2 Sekisui Diagnostics Major Business
7.10.3 Sekisui Diagnostics Influenza Diagnostics Product and Services
7.10.4 Sekisui Diagnostics Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Sekisui Diagnostics Recent Developments/Updates
7.10.6 Sekisui Diagnostics Competitive Strengths & Weaknesses
7.11 Response Biomedical
7.11.1 Response Biomedical Details
7.11.2 Response Biomedical Major Business
7.11.3 Response Biomedical Influenza Diagnostics Product and Services
7.11.4 Response Biomedical Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Response Biomedical Recent Developments/Updates
7.11.6 Response Biomedical Competitive Strengths & Weaknesses
7.12 SA Scientific
7.12.1 SA Scientific Details
7.12.2 SA Scientific Major Business
7.12.3 SA Scientific Influenza Diagnostics Product and Services
7.12.4 SA Scientific Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 SA Scientific Recent Developments/Updates
7.12.6 SA Scientific Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Influenza Diagnostics Industry Chain
8.2 Influenza Diagnostics Upstream Analysis
8.3 Influenza Diagnostics Midstream Analysis
8.4 Influenza Diagnostics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Influenza Diagnostics Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Influenza Diagnostics Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Influenza Diagnostics Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Influenza Diagnostics Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Influenza Diagnostics Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Influenza Diagnostics Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Influenza Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Influenza Diagnostics Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Influenza Diagnostics Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Influenza Diagnostics Players in 2023
Table 12. World Influenza Diagnostics Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Influenza Diagnostics Company Evaluation Quadrant
Table 14. Head Office of Key Influenza Diagnostics Player
Table 15. Influenza Diagnostics Market: Company Product Type Footprint
Table 16. Influenza Diagnostics Market: Company Product Application Footprint
Table 17. Influenza Diagnostics Mergers & Acquisitions Activity
Table 18. United States VS China Influenza Diagnostics Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Influenza Diagnostics Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Influenza Diagnostics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Influenza Diagnostics Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Influenza Diagnostics Revenue Market Share (2019-2024)
Table 23. China Based Influenza Diagnostics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Influenza Diagnostics Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Influenza Diagnostics Revenue Market Share (2019-2024)
Table 26. Rest of World Based Influenza Diagnostics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Influenza Diagnostics Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Influenza Diagnostics Revenue Market Share (2019-2024)
Table 29. World Influenza Diagnostics Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Influenza Diagnostics Market Size by Type (2019-2024) & (USD Million)
Table 31. World Influenza Diagnostics Market Size by Type (2025-2030) & (USD Million)
Table 32. World Influenza Diagnostics Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Influenza Diagnostics Market Size by Application (2019-2024) & (USD Million)
Table 34. World Influenza Diagnostics Market Size by Application (2025-2030) & (USD Million)
Table 35. BD Basic Information, Area Served and Competitors
Table 36. BD Major Business
Table 37. BD Influenza Diagnostics Product and Services
Table 38. BD Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. BD Recent Developments/Updates
Table 40. BD Competitive Strengths & Weaknesses
Table 41. Abbott (Include Alere) Basic Information, Area Served and Competitors
Table 42. Abbott (Include Alere) Major Business
Table 43. Abbott (Include Alere) Influenza Diagnostics Product and Services
Table 44. Abbott (Include Alere) Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Abbott (Include Alere) Recent Developments/Updates
Table 46. Abbott (Include Alere) Competitive Strengths & Weaknesses
Table 47. Roche Basic Information, Area Served and Competitors
Table 48. Roche Major Business
Table 49. Roche Influenza Diagnostics Product and Services
Table 50. Roche Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Roche Recent Developments/Updates
Table 52. Roche Competitive Strengths & Weaknesses
Table 53. SIEMENS Basic Information, Area Served and Competitors
Table 54. SIEMENS Major Business
Table 55. SIEMENS Influenza Diagnostics Product and Services
Table 56. SIEMENS Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. SIEMENS Recent Developments/Updates
Table 58. SIEMENS Competitive Strengths & Weaknesses
Table 59. Analytik Jena Basic Information, Area Served and Competitors
Table 60. Analytik Jena Major Business
Table 61. Analytik Jena Influenza Diagnostics Product and Services
Table 62. Analytik Jena Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Analytik Jena Recent Developments/Updates
Table 64. Analytik Jena Competitive Strengths & Weaknesses
Table 65. Quidel Basic Information, Area Served and Competitors
Table 66. Quidel Major Business
Table 67. Quidel Influenza Diagnostics Product and Services
Table 68. Quidel Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Quidel Recent Developments/Updates
Table 70. Quidel Competitive Strengths & Weaknesses
Table 71. Thermo Fisher Basic Information, Area Served and Competitors
Table 72. Thermo Fisher Major Business
Table 73. Thermo Fisher Influenza Diagnostics Product and Services
Table 74. Thermo Fisher Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Thermo Fisher Recent Developments/Updates
Table 76. Thermo Fisher Competitive Strengths & Weaknesses
Table 77. Meridian Bioscience Basic Information, Area Served and Competitors
Table 78. Meridian Bioscience Major Business
Table 79. Meridian Bioscience Influenza Diagnostics Product and Services
Table 80. Meridian Bioscience Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Meridian Bioscience Recent Developments/Updates
Table 82. Meridian Bioscience Competitive Strengths & Weaknesses
Table 83. BioMerieux Basic Information, Area Served and Competitors
Table 84. BioMerieux Major Business
Table 85. BioMerieux Influenza Diagnostics Product and Services
Table 86. BioMerieux Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. BioMerieux Recent Developments/Updates
Table 88. BioMerieux Competitive Strengths & Weaknesses
Table 89. Sekisui Diagnostics Basic Information, Area Served and Competitors
Table 90. Sekisui Diagnostics Major Business
Table 91. Sekisui Diagnostics Influenza Diagnostics Product and Services
Table 92. Sekisui Diagnostics Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Sekisui Diagnostics Recent Developments/Updates
Table 94. Sekisui Diagnostics Competitive Strengths & Weaknesses
Table 95. Response Biomedical Basic Information, Area Served and Competitors
Table 96. Response Biomedical Major Business
Table 97. Response Biomedical Influenza Diagnostics Product and Services
Table 98. Response Biomedical Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Response Biomedical Recent Developments/Updates
Table 100. SA Scientific Basic Information, Area Served and Competitors
Table 101. SA Scientific Major Business
Table 102. SA Scientific Influenza Diagnostics Product and Services
Table 103. SA Scientific Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 104. Global Key Players of Influenza Diagnostics Upstream (Raw Materials)
Table 105. Influenza Diagnostics Typical Customers
List of Figure
Figure 1. Influenza Diagnostics Picture
Figure 2. World Influenza Diagnostics Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Influenza Diagnostics Total Market Size (2019-2030) & (USD Million)
Figure 4. World Influenza Diagnostics Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Influenza Diagnostics Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Influenza Diagnostics Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Influenza Diagnostics Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Influenza Diagnostics Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Influenza Diagnostics Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Influenza Diagnostics Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Influenza Diagnostics Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Influenza Diagnostics Revenue (2019-2030) & (USD Million)
Figure 13. Influenza Diagnostics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Influenza Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 16. World Influenza Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Influenza Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 18. China Influenza Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Influenza Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Influenza Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Influenza Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Influenza Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 23. India Influenza Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Influenza Diagnostics by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Influenza Diagnostics Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Influenza Diagnostics Markets in 2023
Figure 27. United States VS China: Influenza Diagnostics Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Influenza Diagnostics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Influenza Diagnostics Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Influenza Diagnostics Market Size Market Share by Type in 2023
Figure 31. RIDT
Figure 32. RT-PCR
Figure 33. Cell Culture
Figure 34. Others
Figure 35. World Influenza Diagnostics Market Size Market Share by Type (2019-2030)
Figure 36. World Influenza Diagnostics Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 37. World Influenza Diagnostics Market Size Market Share by Application in 2023
Figure 38. Hospitals
Figure 39. POCT
Figure 40. Others
Figure 41. Influenza Diagnostics Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
btl

Related Reports

Global Influenza Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029 xian22
q3

Global Influenza Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

industry 18 Mar 2023

industry Medical Care

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

jiaGou

Add To Cart

gouMai

Buy Now